Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

INTRODUCTION: Methamphetamine (MA) use disorder is an important public health concern. MA withdrawal is often the first step in ceasing or reducing use. There are no evidence-based withdrawal treatments, and no medication is approved for the treatment of MA withdrawal. Lisdexamfetamine (LDX) dimesil...

Descripción completa

Detalles Bibliográficos
Autores principales: Acheson, Liam S., Ezard, Nadine, Lintzeris, Nicholas, Dunlop, Adrian, Brett, Jonathan, Rodgers, Craig, Gill, Anthony, Christmass, Michael, McKetin, Rebecca, Farrell, Michael, Shoptaw, Steve, Siefried, Krista J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529099/
https://www.ncbi.nlm.nih.gov/pubmed/36190973
http://dx.doi.org/10.1371/journal.pone.0275371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529099/
https://www.ncbi.nlm.nih.gov/pubmed/36190973
http://dx.doi.org/10.1371/journal.pone.0275371

Ejemplares similares